Impact Biomedical (IBO) Retained Earnings (2022 - 2026)
Impact Biomedical (IBO) posted Retained Earnings of $63.2 million for Q1 2026, up 227.56% on a QoQ basis from -$49.5 million in Q4 2025, and up 47.87% year-over-year from $42.7 million in Q1 2025.
Impact Biomedical (IBO) Retained Earnings (2022 - 2026) Analysis & Trends
Impact Biomedical's Retained Earnings history runs 5 years deep, the most recent figure standing at $63.2 million for Q1 2026.
- Quarterly Retained Earnings rose 47.87% year-over-year to $63.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.2 million (up 47.87% YoY) and the FY2025 annual result came in at -$49.5 million, down 31.43% from the prior year.
- Retained Earnings was $63.2 million for Q1 2026 at Impact Biomedical, up from -$49.5 million in the prior quarter.
- Across five years, Retained Earnings topped out at $63.2 million in Q1 2026 and bottomed at -$49.5 million in Q4 2025.
- A 5-year average of $9.7 million and a median of -$8.6 million in 2022 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 460.78% in 2024, while the deepest fall reached 190.63% in 2024.
- Impact Biomedical's Retained Earnings stood at -$8.6 million in 2022, then sank by 50.27% to -$13.0 million in 2023, then plunged by 190.63% to -$37.7 million in 2024, then plunged by 31.43% to -$49.5 million in 2025, then jumped by 227.56% to $63.2 million in 2026.
- Business Quant data shows IBO's Retained Earnings at $63.2 million in Q1 2026, -$49.5 million in Q4 2025, and $42.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | 63.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.15 Mn |
| Dec 31, 2025 | -49.51 Mn |
| Sep 30, 2025 | 42.87 Mn |
| Jun 30, 2025 | 42.87 Mn |
| Mar 31, 2025 | 42.71 Mn |
| Dec 31, 2024 | -37.67 Mn |
| Sep 30, 2024 | 41.84 Mn |
| Jun 30, 2024 | 38.11 Mn |
| Mar 31, 2024 | -13.92 Mn |
| Dec 31, 2023 | -12.96 Mn |
| Sep 30, 2023 | -11.67 Mn |
| Jun 30, 2023 | -10.56 Mn |
| Dec 31, 2022 | -8.63 Mn |